Stocks-2 News

Generational Group Advises EnviroTech International Inc. in its sale to Florida Energy Water and Air, a portfolio company of Compass Group Equity Partners

DALLAS--(BUSINESS WIRE)--Generational Capital Markets (GCM) Member FINRA/SIPC and a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client, EnviroTech International Inc., to Florida Energy Water and Air (FEWA), a portfolio company of Compass Group Equity Partners. The acquisition closed October 1, 2024. Located in Grand Prairie, Texas, EnviroTech International Inc. is a leading provider of premium water treatment solutions for the D.

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of The Toronto-Dominion Bank(TD) Shareholders

NEW YORK, NY / ACCESSWIRE / November 17, 2024 / If you suffered a loss on your The Toronto-Dominion Bank (NYSE:TD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-toronto-dominion-bank-lawsuit-submission-form?prid=112266&wire=1 or contact Joseph E. Levi, Esq.

January 6, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against LILM

NEW YORK, NY / ACCESSWIRE / November 17, 2024 / If you suffered a loss on your Lilium N.V. (OTC PINK:LILM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lilium-n-v-lawsuit-submission-form?prid=112264&wire=1 or contact Joseph E.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi Lawsuit - MGX

NEW YORK, NY / ACCESSWIRE / November 17, 2024 / If you suffered a loss on your Metagenomi, Inc. (NASDAQ:MGX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/metagenomi-lawsuit-submission-form?prid=112262&wire=1 or contact Joseph E. Levi, Esq.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of JFrog Ltd. - FROG

NEW YORK, NY / ACCESSWIRE / November 17, 2024 / Pomerantz LLP is investigating claims on behalf of investors of JFrog Ltd. ("JFrog" or the "Company") (NASDAQ:FROG).

Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neurogene Inc. ("Neurogene" or "the Company") (NASDAQ:NGNE). Investors who purchased Neurogene securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NGNE.

Wolfspeed, Inc. (WOLF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Wolfspeed, Inc. ("Wolfspeed" or "the Company") (NYSE:WOLF). Investors who purchased Wolfspeed securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WOLF.

Innovative Industrial Properties, Inc. (IIPR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innovative Industrial Properties, Inc. ("IIP" or "the Company") (NYSE:IIPR). Investors who purchased IIP securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IIPR.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Celanese Corporation (CE) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Celanese Corporation ("Celanese" or "the Company") (NYSE:CE). Investors who purchased Celanese securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CE.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Marqeta, Inc. (MQ) and Encourages Shareholders to Learn More About the Investigation

NEW YORK, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Marqeta, Inc. ("Marqeta" or "the Company") (NASDAQ:MQ). Investors who purchased Marqeta securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MQ.

Myriad Genetics, Inc. (MYGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. ("Myriad" or "the Company") (NASDAQ:MYGN). Investors who purchased Myriad securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MYGN.

The Bancorp, Inc. (TBBK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Bancorp, Inc. ("Bancorp" or "the Company") (NASDAQ:TBBK). Investors who purchased Bancorp securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TBBK.

Bronstein, Gewirtz & Grossman, LLC Encourages The Estée Lauder Companies, Inc. (EL) Shareholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Estée Lauder Companies, Inc. ("Estée Lauder" or "the Company") (NYSE:EL). Investors who purchased Estée Lauder securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/EL.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against DZS, Inc. (DZSI) And Encourages Stockholders to Reach Out

NEW YORK, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DZS, Inc. ("DZS" or "the Company") (NASDAQ:DZSI). Investors who purchased DZS securities prior to March 10, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/DZSI.

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hasbro, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HAS

NEW YORK, Nov. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Hasbro, Inc. (NASDAQ: HAS) between February 7, 2022 and October 25, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 13, 2025.

Realty Income Will Double During Trump's Presidency

Considering the promise for further interest rate cuts, an improved corporate tax rate structure, and the potential for economic growth, it is a little surprising real estate investment trust (REIT) Realty Income (NYSE:O) stock is down 2% since Donald Trump was elected president.

ACHC INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Acadia Healthcare Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

SAN DIEGO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) publicly traded securities between February 28, 2020 and September 26, 2024, both dates inclusive (the “Class Period”), have until Monday, December 16, 2024 to seek appointment as lead plaintiff of the Acadia Healthcare class action lawsuit. Captioned Kachrodia v. Acadia Healthcare Company, Inc., No. 24-cv-01238 (M.D. Tenn.), the Acadia Healthcare class action lawsuit charges Acadia Healthcare as well as certain of Acadia Healthcare's top current and former executives with violations of the Securities Exchange Act of 1934.

ACHC Investors Have Opportunity to Lead Acadia Healthcare Company, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

NEW YORK , Nov. 17, 2024 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the "Class Period"), of the important December 16, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased Acadia Healthcare securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the presentation of new results from its Phase 1 study of nucresiran (formerly ALN-TTRsc04), a next-generation RNAi therapeutic in development for the treatment of transthyretin (ATTR) amyloidosis. The data were presented in an oral session at the American Heart Association Scientific Sessions 2024 in Chicago. These new results demonstrated that a single dose o.

STK: A Technology Equity Fund With Call Overwrite, A 5.5% Yield And Solid Growth

STK is a closed-end fund that primarily invests in high-growth technology stocks and utilizes call overwrite to reduce volatility and generate income. Besides high growth potential, currently, the fund yields nearly 5.5%, making it a good investment for income investors. Besides moderate income, the past growth record has been excellent. We would rate the fund as a 'hold' for existing owners and a 'buy' for new investors as a diversification in the technology space. However, the new buyers should use dollar-cost-averaging to avoid the risk of buying near the top.